Assessing a pilot scheme of intensive support and assertive linkage in levels of engagement, retention, and recovery capital for people in recovery housing using quasi-experimental methods.


Journal

Journal of substance use and addiction treatment
ISSN: 2949-8759
Titre abrégé: J Subst Use Addict Treat
Pays: United States
ID NLM: 9918541186406676

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 31 05 2023
revised: 05 11 2023
accepted: 22 12 2023
medline: 18 3 2024
pubmed: 2 1 2024
entrez: 30 12 2023
Statut: ppublish

Résumé

Strong and ever-growing evidence highlights the effectiveness of recovery housing in supporting and sustaining substance use disorder (SUD) recovery, especially when augmented by intensive support that includes assertive linkages to community services. This study aims to evaluate a pilot intensive recovery support (IRS) intervention for individuals (n = 175) entering certified Level II and III recovery residences. These individuals met at least three out of five conditions (no health insurance; no driving license; substance use in the last 14 days; current unemployment; possession of less than $75 capital). The study assesses the impact of the IRS on engagement, retention, and changes in recovery capital, compared to the business-as-usual Standard Recovery Support (SRS) approach (n = 1758). The study employed quasi-experimental techniques to create weighted and balanced counterfactual groups. These groups, derived from the Recovery Capital assessment tool (REC-CAP), enabled comparison of outcomes between people receiving IRS and those undergoing SRS. After reweighting for resident demographics, service needs, and barriers to recovery, those receiving IRS exhibited improved retention rates, reduced likelihood of disengagement, and growth in recovery capital after living in the residence for 6-9 months. The results from this pilot intervention indicate that intensive recovery support, which integrates assertive community linkages and enhanced recovery coaching, outperforms a balanced counterfactual group in engagement, length of stay, and recovery capital growth. We suggest that this model may be particularly beneficial to those entering Level II and Level III recovery housing with lower levels of recovery capital at admission.

Identifiants

pubmed: 38159911
pii: S2949-8759(23)00335-1
doi: 10.1016/j.josat.2023.209283
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

209283

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors declare no financial or non-financial competing interests.

Auteurs

Matthew J Belanger (MJ)

Division of Psychology, University of Dundee, Dundee, UK. Electronic address: 2490638@dundee.ac.uk.

Arun Sondhi (A)

Therapeutic Solutions (Addictions) Ltd., London, UK.

Amy A Mericle (AA)

Alcohol Research Group, Public Health Institute, Oakland, CA, USA.

Alessandro Leidi (A)

Statistical Services Centre Ltd., Reading, UK.

Maike Klein (M)

Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.

Beth Collinson (B)

The University of Sheffield, Sheffield, UK.

David Patton (D)

College of Business, Law and Social Sciences, University of Derby, Derby, UK.

William White (W)

Chestnut Health Systems, Granite City, IL, USA.

Hao Chen (H)

Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany.

Anthony Grimes (A)

Virginia Association of Recovery Residences, Virginia, USA.

Matthew Conner (M)

Virginia Association of Recovery Residences, Virginia, USA.

Bob De Triquet (B)

Virginia Association of Recovery Residences, Virginia, USA.

David Best (D)

Centre for Addiction Recovery Research, Leeds Trinity University, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH